A Drug Pump On A Computer Chip

March 20, 1997

ROSSLYN, Va., March 20, 1997 -- Biomedical engineers have built a prototype drug pump the size of a contact lens, a miniature, closed-loop implant that could monitor its own flow rate to ensure a steady stream of medicine.

The pump is still considered large as a microelectromechanical system, in which sensors, actuators and electronics are merged onto a single silicon wafer. The next step will be to shrink the device so it can be mass produced like a computer chip.

The research, in the laboratory of Whitaker Investigator Michael Huff at Case Western Reserve University, is driven partly by managed health care, which wants to keep people out of hospitals, and partly by the needs of diabetics and other patients on regular, intravenous medication.

Huff, who himself is diabetic, hopes his device may be adapted as a closed-loop system for monitoring blood glucose levels and pumping just the right amount of insulin into the bloodstream. "Ideally, an insulin delivery pump would sense the patient¹s blood glucose level and change the dose of insulin accordingly," said Huff, who has begun with a pump and a flow sensor to ensure a constant pumping rate. An insulin sensor would have to be added later.

Huff¹s prototype consists of a rectangular silicon chamber with one of the outer walls made of two thin layers of a titanium-nickel alloy sandwiched around a layer of silicon. The alloy forcefully changes shape when heated to around 60 degrees Celsius (140 F.). "When these materials recover their shape, they can produce very large displacements and forces," Huff said.

To operate the pump, rhythmic pulses of mild electrical current are passed directly through the alloy, setting up a cycle of heating and cooling that causes the metal to flex. This forces the chamber to expand and contract. The expansion pulls fluid into the chamber through an intake valve, and the contraction expels the fluid through an exhaust valve.

The flow sensor is made up of a heater that raises the temperature of the fluid at one point in the flow stream. Two heat sensors downstream detect this hot spot as it passes by. From this measurement the flow rate can be calculated.

The device has been bench tested successfully and is being scaled down for mass production, Huff reported at SPIE¹s Smart Structures and Materials Symposium in San Diego earlier this month.

The field of microelectromechanical systems and micro fabrication research has led to the development of micro devices which have feature sizes down to a micrometer or less. The field, which developed from integrated circuit fabrication techniques, has recently expanded into the medical device market.

"No company wants to build hospital infusion pumps any longer, since the whole health care system is striving to keep people out of hospitals," Huff said. "Drug delivery systems should be based on ambulatory delivery."

Medical care has already begun to feel the influence of microelectromechanical systems. Ten-dollar disposable blood pressure instruments with microscopic pressure sensors are replacing conventional $600 devices that, while reusable, cost another $50 to sterilize and tune up before each use.

About 20 million miniature blood pressure sensors are now being used each year, in addition to other downsized pumps and sensors. But there are still no closed-loop systems on the market that can regulate themselves without a doctor¹s intervention.
-end-


Whitaker Foundation

Related Insulin Articles from Brightsurf:

US Insulin prices 8 times higher than in other nations
Insulin list prices in the United States have increased dramatically over the past decade, with per person insulin spending doubling between 2012 and 2016.

A gatekeeper against insulin resistance in the brain
The brain plays a major role in controlling our blood glucose levels.

Sorting and secreting insulin by expiration date
Visualizing the age of insulin secreting granules in cells allowed researchers to investigate how cells' preference for secreting newer granules is disrupted in diabetes.

Researchers develop a new ultrafast insulin
Stanford researchers tested a new insulin drug in diabetic pigs and found that it was twice as fast-acting as traditional insulin.

Insulin signaling suppressed by decoys
The discovery of an insulin 'decoy' molecule from the lab of Matthew Gill, PhD, in Florida shakes up understanding of insulin signaling, with implications for diabetes, longevity and aging research.

New mechanism for dysfunctional insulin release identified
In a new study, researchers at Uppsala University have identified a previously unknown mechanism that regulates release of insulin, a hormone that lowers blood glucose levels, from the β-cells (beta cells) of the pancreas.

Type 2 diabetes is not just about insulin
Obesity, by promoting the resistance to the action of insulin, is a major risk factor of diabetes.

The insulin under the influence of light
By understanding how the brain links the effects of insulin to light, researchers (UNIGE) are deciphering how insulin sensitivity fluctuates according to circadian cycles.

Does insulin resistance cause fibromyalgia?
Researchers led by a team from The University of Texas Medical Branch at Galveston were able to dramatically reduce the pain of fibromyalgia patients with medication that targeted insulin resistance.

Insulin insights
Insulin triggers genome-wide changes in gene expression via an unexpected mechanism.

Read More: Insulin News and Insulin Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.